Senior Director, Biostatistics - Rare Disease Strategy

Senior Director, Biostatistics - Rare Disease Strategy

Full-Time 80000 - 100000 £ / year (est.) No working from home possible
Ipsen

At a Glance

  • Tasks: Lead statistical science for rare disease programs and mentor a talented team.
  • Company: Ipsen Innovation, a leading pharma company in London.
  • Benefits: Competitive salary, professional development, and a chance to make a real difference.
  • Other info: Join a passionate team dedicated to advancing rare disease treatments.
  • Why this job: Shape impactful trials and collaborate with regulators and academics in a dynamic field.
  • Qualifications: 10+ years in pharma, expert biostatistics knowledge, and strong communication skills.

The predicted salary is between 80000 - 100000 £ per year.

Ipsen Innovation (SAS) in London, United Kingdom, seeks a Senior Director of Biostatistics to lead program‑level statistical science across rare disease assets.

You will mentor a team, shape trial design, and interact with regulators and academics to ensure compliant, high‑impact analyses.

The role requires 10+ years in pharma with leadership, expert biostatistics knowledge, and strong communication in English.

A Ph D is preferred; SAS, R and CDISC proficiency are essential.

#J-18808-Ljbffr

Senior Director, Biostatistics - Rare Disease Strategy employer: Ipsen

Ipsen in Wrexham is an excellent employer, offering a collaborative work culture that prioritises innovation and excellence. Employees benefit from a supportive environment with opportunities for professional growth, all while working in a state-of-the-art packing facility that operates on a convenient Monday to Friday schedule. Join us to be part of a team that values your expertise and contributions in mechanical engineering and vision systems.

Ipsen

Contact Details:

Ipsen Recruitment Team

We think you need these skills to ace Senior Director, Biostatistics - Rare Disease Strategy

Leadership
Biostatistics Expertise
SAS Proficiency
R Proficiency
CDISC Proficiency
Trial Design
Regulatory Interaction